Correlation Between Esperion Therapeutics and Stepan

Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Stepan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Stepan into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Esperion Therapeutics and Stepan Company, you can compare the effects of market volatilities on Esperion Therapeutics and Stepan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Stepan. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Stepan.

Diversification Opportunities for Esperion Therapeutics and Stepan

0.25

Correlation Coefficient

Esperion Therapeutics  Stepan

Modest diversification

The 3 months correlation between Esperion and Stepan is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Stepan Company in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stepan Company and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Stepan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stepan Company has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Stepan go up and down completely randomly.

Pair Corralation between Esperion Therapeutics and Stepan

Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 3.13 times more return on investment than Stepan. However, Esperion Therapeutics is 3.13 times more volatile than Stepan Company. It trades about 0.09 of its potential returns per unit of risk. Stepan Company is currently generating about -0.02 per unit of risk. If you would invest  141.00  in Esperion Therapeutics on September 4, 2024 and sell it today you would earn a total of  184.00  from holding Esperion Therapeutics or generate 130.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Esperion Therapeutics  vs.  Stepan Company

Esperion Therapeutics

Risk-Adjusted Performance

16 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Esperion Therapeutics are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Esperion Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Stepan Company

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Stepan Company are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent fundamental indicators, Stepan is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Esperion Therapeutics and Stepan

The main advantage of trading using opposite Esperion Therapeutics and Stepan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Stepan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stepan will offset losses from the drop in Stepan's long position.

The idea behind Esperion Therapeutics and Stepan Company pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.